UBE Management
Management criteria checks 2/4
UBE's CEO is Masato Izumihara, appointed in Apr 2019, has a tenure of 5.08 years. total yearly compensation is ¥116.10M, comprised of 36.6% salary and 63.4% bonuses, including company stock and options. directly owns 0.052% of the company’s shares, worth ¥145.76M. The average tenure of the management team and the board of directors is 2.1 years and 1.9 years respectively.
Key information
Masato Izumihara
Chief executive officer
JP¥116.1m
Total compensation
CEO salary percentage | 36.6% |
CEO tenure | 5.1yrs |
CEO ownership | 0.05% |
Management average tenure | 2.1yrs |
Board average tenure | 1.9yrs |
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | JP¥14b |
Sep 30 2023 | n/a | n/a | JP¥2b |
Jun 30 2023 | n/a | n/a | -JP¥9b |
Mar 31 2023 | JP¥116m | JP¥43m | -JP¥7b |
Compensation vs Market: Masato's total compensation ($USD737.12K) is about average for companies of similar size in the JP market ($USD831.68K).
Compensation vs Earnings: Insufficient data to compare Masato's compensation with company performance.
CEO
Masato Izumihara (62 yo)
5.1yrs
Tenure
JP¥116,100,000
Compensation
Mr. Masato Izumihara has been President and Chief Executive Officer at Ube Industries, Ltd. since April 1, 2019 and serves as its Company President of Chemicals Company. Mr. Izumihara served as Senior Mana...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 5.1yrs | JP¥116.10m | 0.052% ¥ 145.8m | |
Executive Officer | 1.1yrs | no data | 0.00010% ¥ 278.0k | |
Sr. Managing EO | no data | no data | no data | |
General Manager of Investor & Public Relations Department | no data | no data | no data | |
Executive Officer & GM of Legal Dept. | no data | no data | no data | |
Managing Executive Officer and GM of Performance Polymers & Chemicals Div. | 5.1yrs | no data | no data | |
Managing Executive Officer & GM of Elastomer Div. | 5.1yrs | no data | no data | |
Senior Executive Officer | 2.1yrs | no data | no data | |
Sr. Managing Executive Officer & General Manager | 5.1yrs | no data | no data | |
Managing Executive Officer & GM of Pharmaceutical Div. | 2.1yrs | no data | no data | |
Senior Executive Officer | 2.1yrs | no data | no data | |
Senior Executive Officer | 1.1yrs | no data | no data |
2.1yrs
Average Tenure
Experienced Management: 4208's management team is considered experienced (2.1 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 5.9yrs | JP¥116.10m | 0.052% ¥ 145.8m | |
Executive Officer | less than a year | no data | 0.00010% ¥ 278.0k | |
Chairman of the Board | 10.9yrs | no data | 0.069% ¥ 191.6m | |
Independent Outside Director | less than a year | no data | no data | |
Independent Outside Director | less than a year | no data | no data | |
Director | 1.9yrs | no data | 0.030% ¥ 83.1m | |
Director | 5.3yrs | no data | 0.023% ¥ 65.3m | |
Independent Outside Director | 1.9yrs | no data | 0.00072% ¥ 2.0m | |
Independent Outside Director | 1.9yrs | no data | no data | |
Independent Outside Director | 1.9yrs | no data | no data |
1.9yrs
Average Tenure
65yo
Average Age
Experienced Board: 4208's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.